Clinical trials
Completed Scleroderma, Diffuse trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
148 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 6 |
| 2002 | 3 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 7 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 10 |
| 2014 | 6 |
| 2015 | 6 |
| 2016 | 13 |
| 2017 | 7 |
| 2018 | 4 |
| 2019 | 9 |
| 2020 | 6 |
| 2021 | 11 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 148 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Michigan | 11 |
| Lady Davis Institute | 9 |
| Johns Hopkins University | 6 |
| Assistance Publique - Hôpitaux de Paris | 5 |
| Actelion | 4 |
| Assiut University | 3 |
| Boston University | 3 |
| Duke University | 3 |
| Istanbul University | 3 |
| Khon Kaen University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Diffuse | 148 |
| Scleroderma, Systemic | 77 |
| Raynaud Disease | 16 |
| Lung Diseases, Interstitial | 11 |
| Autoimmune Diseases | 7 |
| Hypertension, Pulmonary | 7 |
| Connective Tissue Diseases | 6 |
| Sjogren's Syndrome | 6 |
| Lupus Erythematosus, Systemic | 5 |
| Pulmonary Fibrosis | 5 |
Trials
Showing 26 to 50 of 148. Each trial links to its page on Pharma Observatory.
48 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.